BAIYU HOLDINGS INC (BYU)

US87250W3016 - Common Stock

0.179  0 (-1.65%)

After market: 0.189 +0.01 (+5.59%)

Fundamental Rating

3

Overall BYU gets a fundamental rating of 3 out of 10. We evaluated BYU against 48 industry peers in the Trading Companies & Distributors industry. While BYU seems to be doing ok healthwise, there are quite some concerns on its profitability. BYU is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

BYU had positive earnings in the past year.
In the past year BYU has reported a negative cash flow from operations.
In the past 5 years BYU reported 4 times negative net income.
BYU had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

BYU's Return On Assets of 1.63% is on the low side compared to the rest of the industry. BYU is outperformed by 70.00% of its industry peers.
With a Return On Equity value of 1.94%, BYU is not doing good in the industry: 78.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 1.63%
ROE 1.94%
ROIC N/A
ROA(3y)0.23%
ROA(5y)-12.73%
ROE(3y)0.28%
ROE(5y)-24.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BYU has a better Profit Margin (6.85%) than 74.00% of its industry peers.
The Operating Margin and Gross Margin are not available for BYU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 6.85%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

BYU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BYU has been increased compared to 1 year ago.
Compared to 5 years ago, BYU has more shares outstanding
Compared to 1 year ago, BYU has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that BYU is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BYU (0.77) is worse than 94.00% of its industry peers.
BYU has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
BYU has a better Debt to Equity ratio (0.01) than 84.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.77
ROIC/WACCN/A
WACC3.87%

2.3 Liquidity

BYU has a Current Ratio of 6.77. This indicates that BYU is financially healthy and has no problem in meeting its short term obligations.
BYU has a Current ratio of 6.77. This is amongst the best in the industry. BYU outperforms 100.00% of its industry peers.
A Quick Ratio of 6.77 indicates that BYU has no problem at all paying its short term obligations.
BYU has a better Quick ratio (6.77) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.77
Quick Ratio 6.77

4

3. Growth

3.1 Past

BYU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 3302.13%, which is quite impressive.
The Revenue has grown by 597.39% in the past year. This is a very strong growth!
The Revenue has been growing by 220.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)3302.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.97%
Revenue 1Y (TTM)597.39%
Revenue growth 3Y140.48%
Revenue growth 5Y220.19%
Sales Q2Q%458.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.14, which indicates a rather cheap valuation of BYU.
Based on the Price/Earnings ratio, BYU is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
BYU is valuated cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.14
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BYU!.
Industry RankSector Rank
Dividend Yield N/A

BAIYU HOLDINGS INC

NASDAQ:BYU (11/20/2024, 8:11:09 PM)

After market: 0.189 +0.01 (+5.59%)

0.179

0 (-1.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner Change90.54%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.94M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.14
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB 0.04
EV/EBITDA N/A
EPS(TTM)1.28
EY715.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS2.4
BVpS8.48
TBVpS4.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 1.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.85%
GM N/A
FCFM N/A
ROA(3y)0.23%
ROA(5y)-12.73%
ROE(3y)0.28%
ROE(5y)-24.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.77
Quick Ratio 6.77
Altman-Z 0.77
F-Score6
WACC3.87%
ROIC/WACCN/A
Cap/Depr(3y)53.25%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3302.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)597.39%
Revenue growth 3Y140.48%
Revenue growth 5Y220.19%
Sales Q2Q%458.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-385.53%
FCF growth 3Y-31.7%
FCF growth 5YN/A
OCF growth 1Y-362.26%
OCF growth 3Y-31.62%
OCF growth 5YN/A